Glaucoma Eyeglass Visual Stimulation Pressure Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current glaucoma treatments do not effectively manage neurodegenerative effects and ocular blood flow, leading to potential vision loss, as they lack a method to control intraocular pressure and provide visual stimulation for patients.
Innovation Solution
A glaucoma treatment eyeglass with visual stimulation that uses a combination of LCD screens and LED light sources to increase ocular blood flow, featuring a pressure control unit and communication capabilities to monitor and adjust pressure values, providing both active and passive visual stimuli to reduce neurodegenerative effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If medical treatment methods (eye drops, surgical, laser) are used to control glaucoma, then intraocular pressure can be managed, but neurodegenerative effects and ocular blood flow remain insufficiently addressed
Solution Approach 1:
The patent combines multiple treatment modalities into a single eyeglass device that integrates pressure control mechanism, visual stimulus generation (LCD screen and LED lights), and communication capabilities. This merging allows simultaneous delivery of pressure control and visual stimulation therapies that were previously separate, thereby addressing both intraocular pressure management and neurodegenerative effects through one unified system.
Solution Approach 2:
The eyeglass device serves multiple functions: it controls intraocular pressure through a pressure control unit, provides visual stimulation via LCD screen and LED lights to enhance ocular blood flow, communicates treatment data to mobile devices, and monitors treatment effectiveness. This multi-functionality transforms a single device into a comprehensive glaucoma treatment system that addresses various aspects of the disease simultaneously.
2Reliability
If visual stimulus is added to increase ocular blood flow, then neurodegenerative effects are reduced, but device complexity increases
Solution Approach 1:
The patent integrates visual stimulus generation components (LCD screen, LED lights) directly into the eyeglass structure, merging the visual stimulation function with the pressure control function in a single unified device. This integration allows the system to deliver both pressure control and visual stimulation therapies simultaneously without requiring separate devices, thereby managing complexity through consolidation rather than multiplication of components.
Solution Approach 2:
The eyeglass device serves multiple functions: it controls intraocular pressure through a pressure control unit, provides visual stimulation via LCD screen and LED lights to enhance ocular blood flow, communicates treatment data to mobile devices, and monitors treatment effectiveness. This multi-functionality transforms a single device into a comprehensive glaucoma treatment system that addresses various aspects of the disease simultaneously.
3Adaptability or versatility
If pressure control and visual stimulation are integrated in eyeglass, then treatment versatility improves, but manufacturing complexity increases
Solution Approach 1:
The patent divides the eyeglass device into distinct functional modules: a pressure control unit for intraocular pressure management, a visual stimulus unit with LCD screen and LED lights for visual stimulation, and a communication unit for data transmission. This segmentation allows each module to be manufactured and tested independently, then assembled into the complete eyeglass system, thereby reducing overall manufacturing complexity while maintaining treatment versatility.
Solution Approach 2:
The eyeglass device serves multiple functions: it controls intraocular pressure through a pressure control unit, provides visual stimulation via LCD screen and LED lights to enhance ocular blood flow, communicates treatment data to mobile devices, and monitors treatment effectiveness. This multi-functionality transforms a single device into a comprehensive glaucoma treatment system that addresses various aspects of the disease simultaneously.
4Loss of information
If communication capabilities are added for data transfer, then treatment monitoring and personalization improve, but device complexity increases
Solution Approach 1:
The patent introduces a communication unit as an intermediary component that enables data transfer between the eyeglass device and external mobile devices. This intermediary facilitates the transmission of treatment data, pressure measurements, and visual stimulus parameters without requiring complex internal processing within the eyeglass itself, thereby managing complexity by offloading data handling to external systems while maintaining comprehensive monitoring capabilities.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The eyeglass effectively manages glaucoma by increasing ocular blood flow, reducing neurodegenerative effects, and allowing for precise pressure control, thereby preventing vision loss and enhancing treatment efficacy.
Implementation Method 1
the glaucoma treatment eyeglass with visual stimulation developed using LCD screens and/or LED light sources
Implementation Method 2
By means of the micro controller available in it for orbital cavity, it calculates the most suitable pressure value and is capable of applying it to the eye of the patient
Data Source
AI summary
A glaucoma treatment eyeglass with visual stimulation includes the parts of visually stimulating screen, pressure control unit, electronic control and communication unit, information display, pressure control valve, eyeglass cavity pressure sensor, flexible sealing gasket, pressure control buttons, electronic control buttons, pressure pipes, external pressure control unit, actively stimulating light source, mini notice screen, mobile device and notice lamp, which patients with glaucoma eye disease may use during the day, increasing the ocular flow of blood by means of visual stimulus according to the condition and level of the disease, decreasing the neurodegenerative effects and ensuring pressure control.